WJ-95 — Wharton’s Jelly · Concentrated Matrix
Wharton’s jelly is the connective tissue matrix of the human umbilical cord — rich in hyaluronic acid, collagen, proteoglycans, and the structural proteins that define connective tissue architecture. Where exosomes restore biological signalling, Wharton’s jelly restores the structural environment in which that signalling is received and expressed. It rebuilds the extracellular matrix — the physical foundation that cellular activity depends on.
WJ-95 is the concentrated Wharton’s jelly formulation in lyophilised format. Lyophilisation allows for precise concentrated placement — making WJ-95 the primary formulation for smaller joint environments where targeted matrix restoration is required rather than broad surface distribution.
WJ-95 is the foundational small joint musculoskeletal formulation — typically paired with EXO-50 for complete structural and signalling support. The Wharton’s jelly restores the architectural environment of the joint. The exosomes deliver sustained biological signalling into that restored environment.
Specifications
Concentration: 95mg · Format: Lyophilised · Source: Human Umbilical Cord · Access: Clinical Only
Manufactured by Platinum Biologics. US donors. Full pathogen screening. COA on every batch.
